Frontage Holdings Corporation (HKG:1521)

Market Cap	2.89B
Revenue (ttm)	1.98B
Net Income (ttm)	6.14M
Shares Out	2.02B
EPS (ttm)	0.00
PE Ratio	470.99
Forward PE	20.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	426,000
Average Volume	736,923
Open	1.410
Previous Close	1.470
Day's Range	1.380 - 1.490
52-Week Range	0.470 - 1.870
Beta	0.37
RSI	46.33
Earnings Date	Aug 26, 2025

About Frontage Holdings

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 1,560
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1521

Financial Performance

In 2024, Frontage Holdings's revenue was $254.91 million, a decrease of -1.90% compared to the previous year's $259.86 million. Earnings were $791,000, a decrease of -92.68%.

Financial numbers in USD